- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- August 2019
Global
From €4295EUR$4,500USD£3,598GBP
The Bio Engineered Stent market is a subset of the larger Stent market. Bio Engineered Stents are medical devices used to treat narrowed or blocked arteries. They are made from biocompatible materials, such as polymers, and are designed to be more flexible and durable than traditional stents. These stents are designed to reduce the risk of restenosis, a condition in which the artery becomes narrowed again after stent placement. Bio Engineered Stents are also designed to reduce the risk of thrombosis, a condition in which a blood clot forms in the artery.
Bio Engineered Stents are used in a variety of medical procedures, including coronary artery bypass grafting, percutaneous coronary intervention, and carotid artery stenting. They are also used in the treatment of peripheral artery disease.
Some companies in the Bio Engineered Stent market include Abbott, Boston Scientific, Medtronic, and Biotronik. Show Less Read more